Urology Symposium
Friday and Saturday, October 9 and 10, 2015
ARIA Resort, Las Vegas
Friday, October 9, 2015
7:00 am
Registration, Continental Breakfast and Exhibits
7:30 am
Poster Session
Resident Presenters
8:15 am
Welcome
Gary Chien, MD – Symposium
Chairman
Upper Tract Oncology
Role of Renal Biopsy in 2015
At the end of this activity, participants should be able to:
• Assess patient for referral for renal biopsy prior to treatment planning; refer to
interventional radiology.
• Interpret renal biopsy result and determine treatment plan.
Moderator: Gary Chien, MD
9:00 am
Management of Upper Tract Urothelial Carcinoma
At the end of this activity, participants should be able to:
•
Recommended treatment option based on individual health status risk
stratification use shared decision making to develop treatment plan.
Surena Matin, MD
9:30 am
To Treat or Not to Treat: That is the Question Management of Small Renal
Masses
At the end of this activity, participants should be able to:

Recommend treatment option based on individual health status risk stratification
and use shared decision making to develop treatment plan
Jaime Landman, MD
8:30 am
10:00 am
Jaime Landman, MD
Break and Exhibits
10:30 am
Robotics Partial Nephrectomy; How I Do It
At the end of this activity, participants should be able to:
•
Identify and anticipate challenging Partial Nephrectomy surgeries and refer
or schedule
•
Utilize techniques from session and manage inter op and post op
complications to improve pt. outcome
Surena Matin, MD,
11:00 am
Panel
Jaime Landman, MD
Surena Matin, MD
11:45 am
Lunch and Networking
Moderator: David Finley, MD
12:45 pm
Contemporary Management of Urethral Cancer
At the end of this activity, participants should be able to:

Discuss and implement multimodal management of UC; refer as needed

Confidently identify UC patients for radical surgery vs more limited surgery.

Counsel patient and manage care with appropriate use of imaging,
chemotherapy, and radiation, to increase survival rates
.5 credits applicable towards Fluroscopy
1:15 pm
The Case for Non Risk Adapted Surveillance of Stage 1 Testicular Cancer
At the end of this activity, participants should be able to:

Implement multimodal management of Testicular Cancer and refer as
needed

Confidently identify and refer Testicular Cancer patients for radical surgery
vs more limited surgery.

Counsel patient and manage care with imaging, chemotherapy, and
radiation to increase survival rates
.5 credits applicable towards Fluroscopy
1:45 pm
Optimal Management of Penile Cancer
At the end of this activity, participants should be able to:

Counsel patients about possible outcomes and treatments ensuring
informed clinical and SDM decision-making for care

Confidently use appropriate imaging studies for categorizing the extent of
disease and prognosis for patients

Incorporate the recommended algorithms into clinical practice to improve
care and outcomes
.25 credits applicable towards Fluroscopy
Curtis Pettaway, MD
Ella Skinner, MD
Curtis Pettaway, MD
2:15 pm
Break
2:30 pm
Challenging Cases of Testes Cancer Management
At the end of this activity, participants should be able to:

Implement multimodal management of Testicular Cancer and refer as
needed

Confidently identify and refer Testicular Cancer patients for radical surgery
vs more limited surgery.

Counsel patient and manage care with imaging, chemotherapy, and
radiation to increase survival rates
Ella Skinner, MD
3:00 pm
Panel
Ella Skinner, MD
Curtis Pettaway, MD,
3:45 pm
Physician Wellness
At the end of this activity, participants should be able to:

Practice resiliency skills to retain the balance of meaning and satisfaction in
work and life

Build peer to peer and physician-patient relationship and provide safe,
quality of care.
Kent K Miyamoto, MD
4:15 pm
Adjourn for the day
Gary Chien, MD
Saturday, October 10, 2015
7:30 am
Continental Breakfast, Exhibits and Poster Session
Resident Presenters
8:20 am
Day 2 Overview and survey location topic
Gary Chien MD
Moderators: Polina Reyblat, MD
and Charles Shapiro, MD
8:30 am
Male Infertility: Evaluation and Treatment
At the end of this activity, participants should be able to:

Conduct a comprehensive clinical and lab diagnostic evaluation of a new
patient with infertility and educate patient regarding results

Develop a treatment plan based on diagnostic work up and initiate treatment
or refer to specialist only when indicated

Analyze EBM regarding infertility and malignancy and provide patient with
comprehensive oncologic counseling and monitoring
Paul Turek, MD
9:00 am
Male Infertility and Later Cancer
Paul Turek, MD
Case Discussions
Charles Shapiro, MD
10:00 am
Break and Exhibits
10:30 am
Health Policy and Economics as Applied to Quality Care and Outcomes in
Urologic Cancers
At the end of this activity, participants should be able to:
•
Evaluate and integrate specific strategies for delivering value based care to
improve quality, efficiency, and patient experience (IHI Triple AIM)
•
Provide accessible/affordable health care (KP Promise) with optimal urologic
outcomes and high patient satisfaction
David Penson, MD
11:00 am
David Penson, MD
12:00 pm
2015 Where Are We with Prostate Cancer Screening?
Case discussion
At the end of this activity, participants should be able to:

Counsel patient regarding current AUA guideline and SCPMG
recommendation for prostate cancer screening; use SDM to determine if
patient will have screening
12:00 - 1:00
Lunch and Networking
Male Health and BPH
Moderators: Mark Lassoff, MD
and Christopher Tenggardjaja,
MD
1:00 pm
Medical Management of Benign Prostatic Hyperplasia
At the end of this activity, participants should be able to:
• Utilize current literature (EBM) to diagnose manage/prescribe appropriately for
BPH
• Educate patients regarding the disease process, available meds, treatment
process and develop treatment plan
Steven Kaplan, MD
1:30 pm
Surgical Management of Benign Prostatic Hyperplasia
At the end of this activity, participants should be able to:

Analyze and apply the use of various devices/modalities for surgically treating
Jason Singh Sandhu, MD

2:00 pm
2:30 pm
patients with BPH to achieve optimal outcomes
Consult with patient using shared decision making regarding surgical options
for BPH to develop a treatment plan
Men’s Health: Where Urology Needs To Lead
At the end of this activity, participants should be able to:
• Diagnose/treat various issues related to voiding, reproductive, and sexual
health in conjunction with patient’s primary care or specialist to improve
patient total care
• Detect the association between metabolic and urologic disorders and manage
lead/coordinate care for men’s health issues
How to Manage Urinary Complications after Cancer Surgery

Evaluate and manage patients with voiding problems after urologic cancer
surgery using current EBM and guidelines
.5 credits applicable towards Geriatrics
Steven Kaplan, MD
Jason Singh Sandhu, MD
3:00 pm
Q & A Panel Cases
Steven Kaplan, MD
Jason Singh Sandhu, MD
4:00 pm
Adjournment
Gary Chien, MD